Eyes Alive Eye Wash

Water


Division 5 Labs, Inc.
Human Otc Drug
NDC 69183-230
Eyes Alive Eye Wash also known as Water is a human otc drug labeled by 'Division 5 Labs, Inc.'. National Drug Code (NDC) number for Eyes Alive Eye Wash is 69183-230. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in Eyes Alive Eye Wash drug includes Water - 980 mg/mL . The currest status of Eyes Alive Eye Wash drug is Active.

Drug Information:

Drug NDC: 69183-230
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Eyes Alive Eye Wash
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Water
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Division 5 Labs, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:WATER - 980 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:OPHTHALMIC
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Feb, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part349
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:DIVISION 5 LABS, INC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1053148
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:059QF0KO0R
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69183-230-04118 mL in 1 BOTTLE (69183-230-04)01 Feb, 2017N/ANo
69183-230-16474 mL in 1 BOTTLE (69183-230-16)01 Feb, 2017N/ANo
69183-230-202 BOTTLE in 1 CARTON (69183-230-20) / 30 mL in 1 BOTTLE (69183-230-01)01 Feb, 2017N/ANo
69183-230-32946 mL in 1 BOTTLE (69183-230-32)01 Feb, 2017N/ANo
69183-230-404 BOTTLE in 1 CARTON (69183-230-40) / 15 mL in 1 BOTTLE (69183-230-00)01 Feb, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose emergency eye wash and skin flush

Product Elements:

Eyes alive eye wash water water water benzalkonium chloride edetate disodium sodium chloride sodium phosphate, dibasic, heptahydrate sodium phosphate, monobasic, monohydrate

Indications and Usage:

Indications for flushing the eye to help relieve irritation, discomfort, burning, stinging, smarting or itching by removing loose foreign material, air pollutants (smog or pollen) or chlorinated water.

Warnings:

Warnings for external use only to avoid contamination, do not touch tip of bottle to any surface do not reuse once opened, discard do not use if solution changes colors or becomes cloudy with contact lenses if bottle is opened or seal is broken stop use and consult a doctor if you experience eye pain changes in vision continued redness or irritation of the eye or if the condition worsen or persists. obtain immediate medical treatment for all open wounds in or near the eyes. keep out of reach of children if swallowed, get medical help or contact a poison control center right away.

Do Not Use:

Warnings for external use only to avoid contamination, do not touch tip of bottle to any surface do not reuse once opened, discard do not use if solution changes colors or becomes cloudy with contact lenses if bottle is opened or seal is broken stop use and consult a doctor if you experience eye pain changes in vision continued redness or irritation of the eye or if the condition worsen or persists. obtain immediate medical treatment for all open wounds in or near the eyes. keep out of reach of children if swallowed, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions to pour-hold bottle securely, twist off top to remove control rate of flow by pressure on the bottle flush the affected eye as needed do not touch bottle tip to eye.

Stop Use:

Stop use and consult a doctor if you experience eye pain changes in vision continued redness or irritation of the eye or if the condition worsen or persists. obtain immediate medical treatment for all open wounds in or near the eyes.

Package Label Principal Display Panel:

Principal display panel - 946 ml bottle label emergency eye wash eyes alive ™ eye wash sterile buffered isotonic saline solution single use item # d5l-235 mfd. for division5 labs, inc. 7555 west 2nd court miami, fl 33014 www.division5labs.com 32 fl.oz. (946 ml) made in the usa principal display panel - 946 ml bottle label

Further Questions:

Questions or comments? call 800.477.2884, m-f 9 am-5 pm eastern time


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.